[Guidelines for the treatment of nephrotic syndrome]

Nihon Jinzo Gakkai Shi. 2011;53(2):78-122.
[Article in Japanese]
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Age Factors
  • Albumins / administration & dosage
  • Angiotensin Receptor Antagonists / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Diet, Protein-Restricted
  • Diet, Sodium-Restricted
  • Diuretics / therapeutic use
  • Exercise Therapy
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Immunosuppressive Agents / therapeutic use
  • Methylprednisolone / administration & dosage
  • Nephrotic Syndrome / classification
  • Nephrotic Syndrome / diagnosis
  • Nephrotic Syndrome / epidemiology
  • Nephrotic Syndrome / therapy*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Practice Guidelines as Topic*
  • Prednisolone / administration & dosage
  • Pulse Therapy, Drug

Substances

  • Albumins
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Diuretics
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Immunosuppressive Agents
  • Platelet Aggregation Inhibitors
  • Prednisolone
  • Methylprednisolone